Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

als, Inc. and Alkermes, Inc., submitted a reply to a complete response letter issued in October 2010 by FDA regarding Bydureon™, an investigational medication for type 2 diabetes. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date of January 28, 2012.
  • The company submitted its reply to a complete response letter by FDA regarding Amyvid™, a molecular Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.

  • The America Invents Act was signed into law, aligning new U.S. patent laws more closely with those from other countries and improving the global competiveness of U.S. innovator companies such as Lilly. The law will provide new advantages for U.S. inventors by streamlining the application process and addressing the backlog of current applications. This new law, which transitions the U.S. from a "first-to-invent" to a "first-inventor-to-file" system, is the most significant overhaul of the U.S. patent system in 175 years.

  • Third-Quarter Reported Results

    In the third quarter of 2011, worldwide total revenue was $6.148 billion, an increase of 9 percent compared with the third quarter of 2010. This 9 percent revenue growth was comprised of increases of 4 percent in volume and 4 percent due to the impact of foreign exchange rates. Price had a negligible impact on revenue growth, reflecting the loss of U.S. patent exclusivity for Gemzar® in November 2010. Total revenue in the U.S. increased 4 percent to $3.273 billion due to higher prices and increased volume. Total revenue outside the U.S. increased 15 percent to $2.874 billion due to the positive impact of foreign exchange rates and increased volume. Third-quarter 2011 total revenue was reduced by approximately $130 million due to the impact of U.S. health care reform.

    Gross margin increased 3.1 percent to $4.810 billion in the third quarte
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... 30, 2014 Stryker brand ambassadors Fred Funk ... 3M Championship Champions Tour event near Minneapolis, MN ... Blaine . Stryker is the official joint replacement products company ... Friday, August 1 st through Sunday, August 3 rd , ... on-site joint health destination located in the Pioneer Press Expo tent ...
    (Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
    (Date:7/30/2014)... and SAN DIEGO , July 30, 2014 ... ARNA ) announced today that an article based on post-hoc ... entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise ... published in the online issue of Obesity , the ... of these analyses was to identify whether there is an ...
    Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
    ... June 2, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: ... presentation at the Jefferies 2011 Global Healthcare Conference in New ... Time. Bruce Cozadd, the company,s chairman and chief executive officer, ... live webcast of presentation may be accessed from the Investors ...
    ... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Bisaro, Watson,s President and Chief Executive Officer, will provide ... the 2011 Goldman Sachs 32nd Annual Global Healthcare Conference ... at the Terranea Resort in Rancho Palos Verdes, California. ...
    Cached Medicine Technology:
    (Date:7/30/2014)... Ramon, CA (PRWEB) July 30, 2014 ... the ancient redwood forests of the Pomo Indians located ... The Pomo called the river Shabaikai, meaning ‘crooked snake’. ... its labor strife and the violence of prohibition and ... Club at Russian River. Here, the most powerful men ...
    (Date:7/30/2014)... 2014 With the recent May 21st opening ... Ground Zero Museum Workshop in the Meatpacking District has been ... Museum Workshop's Carole Barnes, "We have had to re-write the ... travel sites who sell us so tourists don't confuse the ... to what we do and what the new Museum does ...
    (Date:7/30/2014)... for Vedic Studies (WAVES) conference is coming to Fairfield, ... 31 through Sunday, August 3. To watch the main ... the first time such a large and diverse group ... to explore the relevance of ancient Vedic knowledge in ... states of consciousness, and reflections on the various Vedic ...
    (Date:7/30/2014)... 2014 Today, Gen. Arthur T. Dean, ... America (CADCA) , the nation’s leading substance abuse prevention ... New York Times Editorial Board’s call for ... , “CADCA is disappointed in the New York ... national marijuana legalization. The move is shortsighted and completely ...
    (Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Clues to whether a ... simple blood test, a new study suggests. Chemical changes ... hormones may help spur suicidal thoughts and behaviors, the study,s ... help alert doctors to a patient,s risk for suicide, they ... but we have been stymied in our prevention efforts because ...
    Breaking Medicine News(10 mins):Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 2Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 3Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 4Health News:Despite Some Confusion over 9/11 Memorial Opening, Kid-Friendly Ground Zero Museum Workshop on 14th Street Continues It's Mission 5Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3
    ... ... Circulation Heart Failure, a journal of the American Heart Association, ... is more accurate than the current listing criteria for heart transplantation ... intervention. The study conclusions reinforce the science behind the Shape-HFTM Cardiopulmonary ...
    ... ... based company, providing residential and commercial pest control services, is proud to announce the launch ... ... this week, Clark Pest Control’s 2010 television advertising campaign will air on stations across California ...
    ... disabilities related to mobility increased significantly from 1997 to 2007, ... among Americans ages 65 and over, according to a new ... Researchers found a rise in the proportion of Americans ... need for help in daily personal care activities such as ...
    ... drink, study finds , MONDAY, April 5 (HealthDay News) -- ... imbibe a bit too much themselves. , And the same ... relatives are more likely not to consume alcohol themselves, a ... behavior more than would be predicted by chance alone," said ...
    ... still needs testing , MONDAY, April 5 (HealthDay News) ... have found that tick-borne transmission might be preventable by ... infection. , Though to date the strategy has been ... toward development of a vaccine that reduces the risk ...
    ... Addiction rehabilitation center ... available at YouTube , ... TX (Vocus) April 5, 2010 -- With the numerous addiction rehabilitation programs available today, many ... program offering is best suited for their individual needs. In a new video available to ...
    Cached Medicine News:Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 2Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 3Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 4Health News:Marysville Girl Stars in TV Advertising Campaign 2Health News:Middle-aged Americans reporting more mobility related disabilities, study finds 2Health News:Middle-aged Americans reporting more mobility related disabilities, study finds 3Health News:Your Social Network Affects Your Drinking Habits 2Health News:Your Social Network Affects Your Drinking Habits 3Health News:Genetic Engineering Raises Hope for Lyme Disease Vaccine 2Health News:Genetic Engineering Raises Hope for Lyme Disease Vaccine 3Health News:Drug Rehab Treatment Center Explains Rehabilitation Program Using YouTube 2
    HRT II is the smallest scanning laser ever, light, portable and ready for telemedicine....
    ...
    ... Horizon Phacoemulsification System is a ... Lightweight and portable, it offers ... a small console. It also ... perform anterior segment surgery. These ...
    ... tool designed for ophthalmic surgeons. ... reliable, safe and easy to ... (one year for ultrasonic handpiece). ... console, phaco handpiece, foot pedal, ...
    Medicine Products: